Top 3 Trends Impacting the Global Urology Robotic Surgery Market Through 2020: Technavio

Technavio publishes a new market research report on the global urology robotic surgery market from 2016-2020. (Photo: Business Wire)

LONDON--()--Technavio’s latest report on the global urology robotic surgery market provides an analysis on the most important trends expected to impact the market outlook from 2016-2020. Technavio defines an emerging trend as a factor that has the potential to significantly impact the market and contribute to its growth or decline.

Barath Palada, a lead analyst from Technavio, specializing in research on urology devices, says, “The increased prevalence of urological disorders such as prostate cancer, urinary tract infection, urinary blockages, and kidney cancers have increased the demand for urology surgical robots. The robotic surgery market is gaining precedence over other surgeries such as open surgeries and laparoscopic surgeries due to benefits such as less pain, no requirement of blood transfusion, short hospital stays, and less recovery time.”

Request a sample report: http://www.technavio.com/request-a-sample?report=54507

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

The top three emerging trends driving the global urology robotic surgery market according to Technavio healthcare and life sciences research analysts are:

  • Increase in R&D activities
  • Adoption of micro and nano robots in urology surgical procedures
  • Vendor focus on the development of low-cost robotic surgical systems

Increase in R&D activities

The increasing advancements in robotic surgical systems are likely to have a positive impact on market growth. For instance, in January 2016, the US FDA approved a synchronized motion table for the Intuitive Surgical robotic surgical system. This allows surgeons to use gravity to their advantage by moving the table simultaneously with a surgical robot to manipulate the individual body for better surgical access. This table helps surgeons to perform real-time patient positioning for retraction. The process will improve efficiency in the operating room and reduce costs by enhancing surgical access, exposure, and reach. Such initiatives are expected to bring new products to the market thereby generating substantial revenues.

Adoption of micro and nano robots in urology surgical procedures

The market has been witnessing a trend for increased adoption of micro and nano robots in urological surgical procedures. A micro robot is used remotely to move it to desired locations to aid laparoscopic procedures. Nanorobots are robots which are the size of a cell. These robots could be introduced in blood flow for various treatment purposes such as to destroy cancer cells or for tissue repair. Also, the microrobots can be inserted through a single incision rather than the multiple port sites. Micro-robots possess capabilities such as single incision surgery, tissue retraction, and supplementary visualization. “Researchers are focusing on developing such advanced robots owing to their potential benefits in urological surgeries such as prostatectomies. Such new developments are expected to have a positive impact on market growth,” says Barath.

Vendor focus on the development of low-cost robotic surgical systems

The market has been witnessing development in the use of low-cost robotic surgical systems, which is expected to change market dynamics in the future. One of the reasons for low penetration rates in the market is the high cost of robotic surgical systems. Therefore, emerging competitors are currently focusing on developing cost-effective robotic systems and are likely to challenge the dominance of established vendors by providing greater affordability and technological innovation.

Such initiatives will eventually result in the development of low-cost, miniaturized robots. In March 2016, Virtual Incision Corporation announced the successful use of its miniaturized robotically assisted surgical device for colon resection. Due to its much smaller size, the robot is expected to be substantially less expensive than existing robotic alternatives for urology surgery. As there is high demand for low-cost robotic surgical systems, the device is expected to be used in urology procedures as well during the forecast period.

Browse Related Reports:

Do you need a report on a market in a specific geographical cluster or country but can’t find what you’re looking for? Don’t worry, Technavio also takes client requests. Please contact enquiry@technavio.com with your requirements and our analysts will be happy to create a customized report just for you.

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com

Release Summary

Technavio’s latest report on the global urology robotic surgery market provides an analysis on the most important trends expected to impact the market outlook from 2016-2020.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com